Drug intelligence / Profile preview

Modified Shaoyao Gancao decoction

Development stage: Preclinical
Lead developer: Zhejiang Provincial Administration of Traditional Chinese Medicine
Administration: Oral

Overview

Modified Shaoyao Gancao decoction is a traditional Chinese medicine formulation being investigated for its therapeutic effects on accommodative asthenopia. It is currently undergoing clinical trials to study its impact on remodeling brain function related to this condition.

Other names: modified shaoyaogancao decoctionmodified Shaoyao-Gancao Decoctionmodified Shaoyao Gancao Tangmodified Peony and Licorice Decoction

Targets

NeuraminidasePPARGC1A (Peroxisome proliferator–activated receptor gamma coactivator 1-alpha)TRPV1 (Transient receptor potential cation channel subfamily V member 1)

Beyond the preview

Go deeper on Modified Shaoyao Gancao decoction.

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Clinical trials

Follow clinical development from study design and recruitment through results.

Trial phase
Status
Readouts

Indications & development

Explore development by indication, patient population, and geography.

Indications
Development status
Countries

Licensing & deals

Trace asset ownership, licensing agreements, and commercial partnerships.

Partners
Deal terms
Milestones

Patents & exclusivity

Explore the patent landscape and regulatory exclusivity around an asset.

Patents
Expiration dates
Exclusivity

Competitive landscape

Compare development programs by target, modality, and indication.

Competing assets
Targets
Development stage

Research & analysis

Connect source evidence and development news to your research questions.

Publications
News
Analysis

Bring the full picture into focus.

See how Gosset can support your research on Modified Shaoyao Gancao decoction.

Explore the full profile